CVGBM, an investigational cancer vaccine, induced T-cell responses in patients with MGMT-unmethylated glioblastoma.

Prostate cancer imaging developed by university researchers has shown “extremely encouraging” results in its first clinical ...

Researchers at Children's Hospital of Philadelphia (CHOP) and the Perelman School of Medicine at the University of ...

Universal Chimeric Antigen Receptor-Modified AT19 Cells is under clinical development by Chengdu USino Technology Biology and currently in Phase I for Hematological Tumor.